Bigul

Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Meeting Of Board Of Directors Of The Company Scheduled To Be Held On 10Th February, 2023

Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 ,inter alia, to consider and approve (i) the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2022; and (ii) Interim Dividend for the financial year 2022-2023. The record date for the purpose of payment of Interim Dividend for the financial year 2022-2023, would be Saturday, 18th February, 2023, subject to declaration of the said Interim Dividend by the Board of Directors in its meeting to be held on 10th February, 2023.
24-01-2023
Bigul

Alkem Laboratories Ltd - 539523 - Postal Ballot- Details Of The Voting Results Of The Postal Ballot Through Remote E-Voting - Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

In continuation of our letter dated 06th December, 2022 and pursuant to provisions of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the resolution as proposed in the Postal Ballot Notice dated 11th November, 2022 has been passed by the Members of the Company with requisite majority. We are enclosing herewith the details regarding the voting results of the business transacted through Postal Ballot by remote e-voting process in the prescribed format alongwith the Scrutinizer's Report. The same are also being uploaded on Company's website viz. https://www.alkemlabs.com/Postal-Ballot.php The approval is deemed to have been received on the last date of remote e-voting, i.e. 05th January, 2023.
06-01-2023
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of advertisement published in today''s Newspapers viz. Business Standard (English) and Mumbai Lakshadeep (Marathi), inviting the attention of the concerned shareholders to submit their claims with respect to the unclaimed/unpaid Interim Dividend for the FY 2015-2016 and all subsequent years, which is unclaimed/unpaid for the last seven consecutive years, failing which their shares would be transferred to Investor Education and Protection Fund Authority in accordance with Section 124(6) of the Companies Act, 2013 and the rules made thereunder. The copy of the aforesaid newspaper advertisement is also available on the website of the Company at www.alkemlabs.com. Kindly take the same on record.
05-01-2023
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Acquisition

Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby wish to inform you that the Company has entered into a Securities Subscription Agreement and Shareholders' Agreement dated 23rd December, 2022 with Enzene Biosciences Limited, a subsidiary of the Company ('Enzene'), Eight Roads Ventures India Healthcare IV, L.P. ('Eight Roads Ventures') and F-Prime Capital Partners Life Sciences Fund VI LP ('F-Prime Capital') in connection with an acquisition of a minority stake by Eight Roads Ventures and F-Prime Capital in Enzene. In this regard, the necessary disclosures/ information required to be submitted pursuant to Regulation 30 of SEBI Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 is enclosed as Annexure I. A copy of this disclosure will be made available on the Company's website as well in accordance with Regulation 30(8) of the SEBI Listing Regulations. Kindly take note of the same.
23-12-2022
Bigul

Alkem Laboratories Ltd - 539523 - Closure of Trading Window

This is to inform you that in terms of Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 30th December, 2022 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and nine months ended 31st December, 2022 are communicated to the Stock Exchanges.
23-12-2022
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith is the details of Analyst/ Institutional Investor meeting to be conducted.
22-12-2022
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith are the details of Analyst/ Institutional Investor meetings scheduled to be conducted.
16-12-2022
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith is the details of Analyst/ Institutional Investor meeting to be conducted.
12-12-2022
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 30 and 47 read alongwith Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulation"), please find enclosed herewith a copy of advertisement published in today''s Newspapers viz. Business Standard (English) and Mumbai Lakshadeep (Marathi) regarding Postal Ballot Notice and E-Voting information. The same is also available on the website of the Company at www.alkemlabs.com. Kindly take the same on record.
07-12-2022
Bigul

Alkem Laboratories Ltd - 539523 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

In furtherance to our intimation dated 11.11.2022, this is to inform you that pursuant to the provisions of Section 110 and other applicable provisions, if any, of the Companies Act, 2013 read with Rule 20 and 22 of the Companies (Management and Administration) Rules, 2014, the Company is in the process of conducting Postal Ballot (only by means of remote e-voting) for seeking approval of Members of the Company for the business as specified in the Postal Ballot Notice dated 11.11.2022 ('Postal Ballot Notice'). In terms of Regulation 30 of SEBI Listing Regulations, please find enclosed herewith the Postal Ballot Notice. The remote e-voting period commences on Wednesday, 07.12.2022 at 09.00 am and shall remain open for a period of 30 days i.e. till Thursday, 05.01.2023 at 05.00 pm. CS Mannish L. Ghia, Partner, M/s Manish Ghia & Associates, Company Secretaries, Mumbai has been appointed as Scrutinizer for conducting the Postal Ballot process in a fair and transparent manner.
06-12-2022
Next Page
Close

Let's Open Free Demat Account